NCT03923153

Brief Summary

Stable angina is a cardiac pathology that adversely affects the quality of life of the patient, which develops as a result of narrowing of the coronary vessels developing in atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely investigated the effects of exercise training in patients with stable angina. No study investigated the effects of inspiratory muscle training in patients with stable angina.Investigators aimed to investigate the effects of inspiratory muscle training on aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP) muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
Last Updated

May 6, 2021

Status Verified

May 1, 2021

Enrollment Period

1.4 years

First QC Date

April 17, 2019

Last Update Submit

May 5, 2021

Conditions

Keywords

inspiratory muscle trainigquality of lifeaerobic capacitydepressionfatique

Outcome Measures

Primary Outcomes (1)

  • Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week

    Mouth pressure device( MicroRPM, Micro Medical England)

    Baseline, after 8 week

Secondary Outcomes (4)

  • Change from Baseline Functional exercise capacity at 8 week

    Baseline, after 8 week

  • Change from Pulmonary functions at 8 week

    Baseline, after 8 week

  • Fatigue

    Baseline, after 8 week

  • Depression

    Baseline,after 8 week

Other Outcomes (1)

  • Quality life

    Baseline, after 8 week

Study Arms (2)

Inspiratory muscle training group

ACTIVE COMPARATOR

Inspiratory muscle training group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device

Device: Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)

Sham group

SHAM COMPARATOR

Sham group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device

Device: Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)

Interventions

Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.

Inspiratory muscle training group

Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.

Sham group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • No contraindication for pulmonary physiotherapy
  • Anjina patients who are clinically stable
  • have no other disease that may affect respiratory function
  • Individuals who have the good cooperation

You may not qualify if:

  • Patients under the age of 18
  • Pregnancy
  • Active infection
  • Patients with known malignancies
  • patients without consent
  • known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF \<40%)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatay Mustafa Kemal University

Hatay, Merkez, 31010, Turkey (Türkiye)

Location

Related Publications (3)

  • Kellens I, Cannizzaro F, Gouilly P, Crielaard JM. [Inspiratory muscles strength training in recreational athletes]. Rev Mal Respir. 2011 May;28(5):602-8. doi: 10.1016/j.rmr.2011.01.008. Epub 2011 Apr 19. French.

    PMID: 21645830BACKGROUND
  • Long L, Anderson L, Dewhirst AM, He J, Bridges C, Gandhi M, Taylor RS. Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev. 2018 Feb 2;2(2):CD012786. doi: 10.1002/14651858.CD012786.pub2.

    PMID: 29394453BACKGROUND
  • American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624. doi: 10.1164/rccm.166.4.518. No abstract available.

    PMID: 12186831BACKGROUND

MeSH Terms

Conditions

Angina, StableDepression

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Aysel yıldız, assoc prof

    Marmara University Faculty of Health Sciences

    STUDY DIRECTOR
  • Irem Hüzmeli, Msc

    Mustafa Kemal University

    STUDY CHAIR
  • Oğuz Akkuş, assist prof

    Mustafa Kemal University

    PRINCIPAL INVESTIGATOR
  • Fatih Yalçın, Prof.

    Mustafa Kemal University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

April 17, 2019

First Posted

April 22, 2019

Study Start

April 15, 2019

Primary Completion

August 30, 2020

Study Completion

August 30, 2020

Last Updated

May 6, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations